Inflammatory Mediators in Erythema Migrans

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

October 31, 2020

Conditions
Erythema Migrans
Interventions
DRUG

Doxycycline 7 days

Patient will be treated with doxycycline orally, 100 mg, bid, 7 days

DRUG

Doxycycline 14 days

Patient will be treated with doxycycline orally, 100 mg, bid, 14 days

Trial Locations (1)

Unknown

University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
collaborator

University of Ljubljana School of Medicine, Slovenia

OTHER

lead

University Medical Centre Ljubljana

OTHER

NCT03956212 - Inflammatory Mediators in Erythema Migrans | Biotech Hunter | Biotech Hunter